Emma has over 15 years’ experience as an equity analyst, mainly across the biotech, pharma and med-tech sectors, including more than 10 years as an analyst at Edison Group where she covered a range of pan-European mid-cap stocks.
Introducing the analyst: Emma Ulker
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE